MSI2 and chronic myelogenous leukemia, BCR-ABL1 positive: Conversely, NUP98-HOXA9, as a genetic event in blast crisis CML, up-regulates MSI2 which in turn post-transcriptionally inhibits Numb expression, and finally results in propagation and progression of the aggressive state [8, 29, 30].